Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Dong Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-6609-0776; OpenAlex author ID A5101336927. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. ISG15 Promotes Progression and Gemcitabine Resistance of Pancreatic Cancer Cells Through ATG7. Last author DOI 10.7150/ijbs.85424↗
  2. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis. Last author DOI 10.18632/oncotarget.15692↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pingting Zhou · 2 shared papers, 2017–2024 · strength 0.28
  2. Yiling Meng · 1 shared paper, 2024 · strength 0.21
  3. Fu-Rao Liu · 1 shared paper, 2017 · strength 0.07
  4. Yao Zong YUAN · 1 shared paper, 2017 · strength 0.07
  5. Bo Li · 1 shared paper, 2017 · strength 0.07
  6. Yanyan Li · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.